諾瓦瓦克斯:新冠疫苗的開發和生產面臨延遲

諾瓦瓦克斯醫藥表示已推遲旗下新冠疫苗尋求監管許可的計劃,同時原材料短缺因素正在放緩其提升疫苗生產的速度 … 報道稱,延遲可能令發展中國家擴大疫苗接種的努力遇挫,這些國家一直在應對目前可用疫苗有限的問題 … 諾瓦瓦克斯之前曾表示,預計將在6月底前完成其新冠疫苗在美國、英國及其他歐洲國家的監管授權申請。

媒體報道:
21-05-10 鈦媒體: 要不要保護新冠疫苗專利,美國說了算嗎?
21-05-10 界面: 諾瓦瓦克斯:新冠疫苗的開發和生產面臨延遲
21-05-10 Engadget: Novavax Drops on Reports of Vaccine Delay
21-05-10 Business Insider: Fox & Friends hosts say they’Re all vaccinated and it gave them a sense of ‘relief’
21-05-10 Business Insider: A 23-year-old Italian woman received 6 Times the recommended amount of Pfizer’s coronavirus vaccine
21-05-10 Business Insider: The US just authorized Pfizer-BioNTech’s coronavirus vaccine for teenagers, making it the First COVID-19 shot OK’d for 12- to 15-year-olds
21-05-10 The Verge: FDA clears Pfizer COVID-19 vaccine for kids ages 12 to 15
21-05-10 SlashGear: FDA says 12-15 year olds can get Pfizer-BioNTech COVID-19 vaccine
21-05-10 Gizmodo: FDA Authorizes Pfizer/BioNTech COVID-19 Vaccine For Teens
21-05-10 Wired: US Teens Can Get Their Covid Shot. What’s Next for Schools?
21-05-10 Business Insider: Los Angeles County could reach herd immunity by end of July, Health officials say

相關事件:
21-05-10 諾瓦瓦克斯:新冠疫苗的開發和生產面臨延遲
21-03-20 歐洲科學家確定阿斯利康疫苗與血栓存在聯繫,接種人群已達1700萬
20-10-12 國葯集團新冠疫苗在北京、武漢兩地開放預約接種
20-09-02 日媒:日本想在奧運會前全民接種新冠疫苗
20-08-31 《柳葉刀》:全球需有效、快速評估多種新冠候選疫苗